Patient characteristics of the cohort (N = 328)
| Characteristic . | Number . |
|---|---|
| Age of transplantation, years | |
| Median (range) | 50.4 (17-66) |
| Sex, number (%) | |
| Male | 178 (54%) |
| Female | 150 (46%) |
| Diagnosis, number (%) | |
| AML | 142 (43%) |
| ALL | 49 (15%) |
| NHL | 31 (9%) |
| CLL | 24 (7%) |
| MM | 18 (5%) |
| MDS | 16 (5%) |
| Other | 48 (15%) |
| Type of allogeneic transplantation, number (%) | |
| UCB | 46 (14%) |
| MUD | 137 (42%) |
| SIB | 145 (44%) |
| GVHD, number (%) | |
| Acute grade I | 42 (13%) |
| Acute grades II-IV | 130 (40%) |
| Chronic limited | 32 (10%) |
| Chronic extensive | 122 (37%) |
| Patients alive | |
| Number (%) | 180 (55%) |
| Time to follow-up (months) | |
| Median (range) | 40.9 (10-77) |
| Characteristic . | Number . |
|---|---|
| Age of transplantation, years | |
| Median (range) | 50.4 (17-66) |
| Sex, number (%) | |
| Male | 178 (54%) |
| Female | 150 (46%) |
| Diagnosis, number (%) | |
| AML | 142 (43%) |
| ALL | 49 (15%) |
| NHL | 31 (9%) |
| CLL | 24 (7%) |
| MM | 18 (5%) |
| MDS | 16 (5%) |
| Other | 48 (15%) |
| Type of allogeneic transplantation, number (%) | |
| UCB | 46 (14%) |
| MUD | 137 (42%) |
| SIB | 145 (44%) |
| GVHD, number (%) | |
| Acute grade I | 42 (13%) |
| Acute grades II-IV | 130 (40%) |
| Chronic limited | 32 (10%) |
| Chronic extensive | 122 (37%) |
| Patients alive | |
| Number (%) | 180 (55%) |
| Time to follow-up (months) | |
| Median (range) | 40.9 (10-77) |
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; GVHD, graft versus host disease; MDS, myelodysplastic syndrome; MM, multiple myeloma; MUD, matched unrelated donor; NHL, non-Hodgkin's lymphoma; SIB, sibling; UCB, umbilical cord blood.